Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

Disease:

BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation, BRIP1 Gene Mutation, Estrogen Receptor Negative, HER2/Neu Negative, MLH1 Gene Mutation, MSH2 Gene Mutation, MSH6 Gene Mutation, PALB2 Gene Mutation, PMS2 Gene Mutation, Progesterone Receptor Negative, RAD51C Gene Mutation, RAD51D Gene Mutation, Triple-Negative Breast Carcinoma

Study phase:

Not applicable

Physician name:

Roni Wilke

Department:

Gynecologic Oncology & Reproductive Medicine

For general questions about clinical trials:

1-877-632-6789